Kiss Lajos Sándor, Lakatos Péter László
Semmelweis Egyetem, Altalános Orvostudományi Kar I. Belgyógyászati Klinika Budapest.
Orv Hetil. 2010 Feb 21;151(8):293-301. doi: 10.1556/OH.2010.28813.
Clinical presentation at diagnosis and disease course of both Crohn's disease (CD) and ulcerative colitis (UC) are heterogeneous and variable over time. During follow up, intestinal strictures or perforation may eventually develop at most patients with CD, and significant number of patients will undergo surgery. Much emphasis was laid in recent years on the determination of important predictive factors. Since early introduction of immunomodulators and/or biologicals might be justified in patients at risk for disease progression, so it is important to identify these patients as soon as possible. This review article summarizes the available literature on important clinical, endoscopic, fecal, serological/routine laboratory and genetic factors and hopefully will assist clinicians in the decision making of daily practice when choosing the treatment strategy for their patients with inflammatory bowel diseases.
克罗恩病(CD)和溃疡性结肠炎(UC)在诊断时的临床表现以及疾病进程具有异质性,且会随时间变化。在随访期间,大多数CD患者最终可能会出现肠道狭窄或穿孔,并且相当数量的患者将接受手术。近年来,人们非常重视确定重要的预测因素。由于对于有疾病进展风险的患者,尽早引入免疫调节剂和/或生物制剂可能是合理的,因此尽快识别这些患者很重要。这篇综述文章总结了关于重要临床、内镜、粪便、血清学/常规实验室和遗传因素的现有文献,有望帮助临床医生在为炎症性肠病患者选择治疗策略时进行日常临床决策。